These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 22086726

  • 41. Friedreich's ataxia: oxidative stress and cytoskeletal abnormalities.
    Sparaco M, Gaeta LM, Santorelli FM, Passarelli C, Tozzi G, Bertini E, Simonati A, Scaravilli F, Taroni F, Duyckaerts C, Feleppa M, Piemonte F.
    J Neurol Sci; 2009 Dec 15; 287(1-2):111-8. PubMed ID: 19748629
    [Abstract] [Full Text] [Related]

  • 42. Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia.
    Abeti R, Uzun E, Renganathan I, Honda T, Pook MA, Giunti P.
    Pharmacol Res; 2015 Sep 15; 99():344-50. PubMed ID: 26141703
    [Abstract] [Full Text] [Related]

  • 43. Candida albicans lacking the frataxin homologue: a relevant yeast model for studying the role of frataxin.
    Santos R, Buisson N, Knight SA, Dancis A, Camadro JM, Lesuisse E.
    Mol Microbiol; 2004 Oct 15; 54(2):507-19. PubMed ID: 15469520
    [Abstract] [Full Text] [Related]

  • 44. Iron metabolism and mitochondrial abnormalities in Friedreich ataxia.
    Pandolfo M.
    Blood Cells Mol Dis; 2002 Oct 15; 29(3):536-47; discussion 548-52. PubMed ID: 12547248
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Frataxin is essential for extramitochondrial Fe-S cluster proteins in mammalian tissues.
    Martelli A, Wattenhofer-Donzé M, Schmucker S, Bouvet S, Reutenauer L, Puccio H.
    Hum Mol Genet; 2007 Nov 15; 16(22):2651-8. PubMed ID: 17597094
    [Abstract] [Full Text] [Related]

  • 47. Ferroptosis as a Novel Therapeutic Target for Friedreich's Ataxia.
    Cotticelli MG, Xia S, Lin D, Lee T, Terrab L, Wipf P, Huryn DM, Wilson RB.
    J Pharmacol Exp Ther; 2019 Apr 15; 369(1):47-54. PubMed ID: 30635474
    [Abstract] [Full Text] [Related]

  • 48. Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia.
    Cavadini P, O'Neill HA, Benada O, Isaya G.
    Hum Mol Genet; 2002 Feb 01; 11(3):217-27. PubMed ID: 11823441
    [Abstract] [Full Text] [Related]

  • 49. Frataxin deficiency causes upregulation of mitochondrial Lon and ClpP proteases and severe loss of mitochondrial Fe-S proteins.
    Guillon B, Bulteau AL, Wattenhofer-Donzé M, Schmucker S, Friguet B, Puccio H, Drapier JC, Bouton C.
    FEBS J; 2009 Feb 01; 276(4):1036-47. PubMed ID: 19154341
    [Abstract] [Full Text] [Related]

  • 50. Yeast frataxin mutants display decreased superoxide dismutase activity crucial to promote protein oxidative damage.
    Irazusta V, Obis E, Moreno-Cermeño A, Cabiscol E, Ros J, Tamarit J.
    Free Radic Biol Med; 2010 Feb 01; 48(3):411-20. PubMed ID: 19932164
    [Abstract] [Full Text] [Related]

  • 51. Reduction in frataxin causes progressive accumulation of mitochondrial damage.
    Karthikeyan G, Santos JH, Graziewicz MA, Copeland WC, Isaya G, Van Houten B, Resnick MA.
    Hum Mol Genet; 2003 Dec 15; 12(24):3331-42. PubMed ID: 14570713
    [Abstract] [Full Text] [Related]

  • 52. The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast.
    Campanella A, Isaya G, O'Neill HA, Santambrogio P, Cozzi A, Arosio P, Levi S.
    Hum Mol Genet; 2004 Oct 01; 13(19):2279-88. PubMed ID: 15282205
    [Abstract] [Full Text] [Related]

  • 53. The role of oxidative stress in Friedreich's ataxia.
    Lupoli F, Vannocci T, Longo G, Niccolai N, Pastore A.
    FEBS Lett; 2018 Mar 01; 592(5):718-727. PubMed ID: 29197070
    [Abstract] [Full Text] [Related]

  • 54. Friedreich ataxia: a paradigm for mitochondrial diseases.
    Puccio H, Koenig M.
    Curr Opin Genet Dev; 2002 Jun 01; 12(3):272-7. PubMed ID: 12076669
    [Abstract] [Full Text] [Related]

  • 55. Methylene blue rescues heart defects in a Drosophila model of Friedreich's ataxia.
    Tricoire H, Palandri A, Bourdais A, Camadro JM, Monnier V.
    Hum Mol Genet; 2014 Feb 15; 23(4):968-79. PubMed ID: 24105471
    [Abstract] [Full Text] [Related]

  • 56. Frataxin and mitochondrial FeS cluster biogenesis.
    Stemmler TL, Lesuisse E, Pain D, Dancis A.
    J Biol Chem; 2010 Aug 27; 285(35):26737-26743. PubMed ID: 20522547
    [Abstract] [Full Text] [Related]

  • 57. Peptide SS-31 upregulates frataxin expression and improves the quality of mitochondria: implications in the treatment of Friedreich ataxia.
    Zhao H, Li H, Hao S, Chen J, Wu J, Song C, Zhang M, Qiao T, Li K.
    Sci Rep; 2017 Aug 29; 7(1):9840. PubMed ID: 28852135
    [Abstract] [Full Text] [Related]

  • 58. Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich's ataxia.
    Chiang S, Kovacevic Z, Sahni S, Lane DJ, Merlot AM, Kalinowski DS, Huang ML, Richardson DR.
    Clin Sci (Lond); 2016 Jun 01; 130(11):853-70. PubMed ID: 27129098
    [Abstract] [Full Text] [Related]

  • 59. Heterotrifunctional chemical cross-linking mass spectrometry confirms physical interaction between human frataxin and ISU.
    Watson HM, Gentry LE, Asuru AP, Wang Y, Marcus S, Busenlehner LS.
    Biochemistry; 2012 Sep 04; 51(35):6889-91. PubMed ID: 22897349
    [Abstract] [Full Text] [Related]

  • 60. Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism.
    Obis È, Irazusta V, Sanchís D, Ros J, Tamarit J.
    Free Radic Biol Med; 2014 Aug 04; 73():21-33. PubMed ID: 24751525
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.